Lobar pneumonia caused by Ralstonia pickettii in a sixty-five-year-old Han Chinese man: a case report
Related Experiment Videos
Wensen Pan1, Zhiming Zhao, Mei Dong
1Department of Reproductive Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, China. pwszzmxx@sina.com.cn.
Introduction:
Ralstonia pickettii is a gram-negative, oxidase-positive bacillus and is an emerging pathogen found in infections described in hospital settings. The cases reported in the literature mostly are nosocomial infections due to contaminated blood products, sterile water, saline, treatment fluids and venous catheters. Human infection unrelated to contaminated solutions is rare. We report a case of lobar pneumonia and pulmonary abscess caused by Ralstonia pickettii in an older patient.
Case Presentation:
A sixty-five-year old Han Chinese man presented having had cough, expectoration, chest pain and fever lasting for twenty days. His medical history was notable for hypertension over the previous ten years, and the habit of smoking for forty years. A thoracic computed tomography scan supported the diagnosis of right-sided lobar pneumonia. A lung biopsy was done and pathological analysis confirmed lobar pneumonia. Two lung biopsy specimens from separate sites grew Ralstonia pickettii. After six days, a repeat thoracic scan revealed a right-sided abscess. A thoracentesis was performed and the purulent fluid grew Ralstonia pickettii. The chest tube remained inserted to rinse the cavity with sterile sodium chloride. He received an antibiotic course of intravenous cefoperazone sodium-sulbactam sodium for eighteen days and imipenem-cilastatin for twelve days. A repeat chest X-ray revealed resolution of the pulmonary abscess and improvement of pneumonia. He remained afebrile and free of respiratory symptoms after treatments.
Conclusion:
This case demonstrates a Ralstonia pickettii infection in the absence of an obvious nosocomial source. It is possible that such cases will become common in the future. Therefore, further studies are needed to evaluate its sensitivity to common antibiotics.
Insights
This case highlights Ralstonia pickettii pneumonia and abscess in an older patient without a clear hospital-acquired source. Further research is needed to understand its antibiotic sensitivity for emerging infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Ralstonia pickettii is an emerging gram-negative pathogen often linked to nosocomial infections.
- Human infections with Ralstonia pickettii unrelated to contaminated solutions are rare.
- This study focuses on a community-acquired case of Ralstonia pickettii infection.
Purpose of the Study:
- To report a rare case of lobar pneumonia and pulmonary abscess caused by Ralstonia pickettii.
- To describe the clinical presentation, diagnosis, and treatment of this infection.
- To emphasize the need for further investigation into Ralstonia pickettii antibiotic sensitivities.
Main Methods:
- A case presentation of a sixty-five-year-old male with symptoms of pneumonia.
- Diagnostic procedures included thoracic CT scan, lung biopsy, and thoracentesis.
- Microbiological analysis confirmed Ralstonia pickettii in lung biopsy and abscess fluid.
- Treatment involved a course of intravenous antibiotics (cefoperazone sodium-sulbactam sodium and imipenem-cilastatin).
Main Results:
- Ralstonia pickettii was identified as the causative agent of lobar pneumonia and a subsequent pulmonary abscess.
- The patient successfully recovered after a course of broad-spectrum antibiotics and chest tube drainage.
- Clinical and radiological resolution of pneumonia and abscess was observed post-treatment.
Conclusions:
- This case illustrates a Ralstonia pickettii infection occurring without an apparent nosocomial origin.
- The increasing incidence of such infections suggests a need for heightened awareness.
- Further studies are crucial to determine the antibiotic susceptibility patterns of Ralstonia pickettii.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology